DK586784D0 - Thiazid-blandet anion/kationkompleks - Google Patents

Thiazid-blandet anion/kationkompleks

Info

Publication number
DK586784D0
DK586784D0 DK586784A DK586784A DK586784D0 DK 586784 D0 DK586784 D0 DK 586784D0 DK 586784 A DK586784 A DK 586784A DK 586784 A DK586784 A DK 586784A DK 586784 D0 DK586784 D0 DK 586784D0
Authority
DK
Denmark
Prior art keywords
thiazide
salts
achieve
thiazides
administration
Prior art date
Application number
DK586784A
Other languages
English (en)
Other versions
DK586784A (da
Inventor
Ronald B Miller
Stewart Thomas Leslie
Peter Hofer
Alfred Halpern
Original Assignee
Euro Celtique Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Family has litigation
First worldwide family litigation filed litigation Critical https://patents.darts-ip.com/?family=24234891&utm_source=google_patent&utm_medium=platform_link&utm_campaign=public_patent_search&patent=DK586784(D0) "Global patent litigation dataset” by Darts-ip is licensed under a Creative Commons Attribution 4.0 International License.
Application filed by Euro Celtique Sa filed Critical Euro Celtique Sa
Publication of DK586784D0 publication Critical patent/DK586784D0/da
Publication of DK586784A publication Critical patent/DK586784A/da

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/54—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one sulfur as the ring hetero atoms, e.g. sulthiame
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/58—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. poly[meth]acrylate, polyacrylamide, polystyrene, polyvinylpyrrolidone, polyvinylalcohol or polystyrene sulfonic acid resin
    • A61K47/585—Ion exchange resins, e.g. polystyrene sulfonic acid resin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/50—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates
    • A61K47/51—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent
    • A61K47/56—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule
    • A61K47/61—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient the non-active ingredient being chemically bound to the active ingredient, e.g. polymer-drug conjugates the non-active ingredient being a modifying agent the modifying agent being an organic macromolecular compound, e.g. an oligomeric, polymeric or dendrimeric molecule the organic macromolecular compound being a polysaccharide or a derivative thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/10—Antioedematous agents; Diuretics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Cardiology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Diabetes (AREA)
  • Hematology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Nitrogen- Or Sulfur-Containing Heterocyclic Ring Compounds With Rings Of Six Or More Members (AREA)
  • Hydrogenated Pyridines (AREA)
  • Eye Examination Apparatus (AREA)
  • Measuring Pulse, Heart Rate, Blood Pressure Or Blood Flow (AREA)
  • Medicinal Preparation (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Thiazole And Isothizaole Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Compositions Of Macromolecular Compounds (AREA)
  • Medicines Containing Plant Substances (AREA)
DK586784A 1983-12-09 1984-12-07 Thiazid-blandet anion/kationkompleks DK586784A (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US06/559,755 US4898729A (en) 1983-12-09 1983-12-09 Treatment of hypertension, compounds and compositions for antihypertension and diuresis

Publications (2)

Publication Number Publication Date
DK586784D0 true DK586784D0 (da) 1984-12-07
DK586784A DK586784A (da) 1985-06-10

Family

ID=24234891

Family Applications (1)

Application Number Title Priority Date Filing Date
DK586784A DK586784A (da) 1983-12-09 1984-12-07 Thiazid-blandet anion/kationkompleks

Country Status (17)

Country Link
US (1) US4898729A (da)
EP (1) EP0154009B1 (da)
JP (4) JPS60139620A (da)
AT (1) ATE91416T1 (da)
AU (2) AU564078B2 (da)
CA (1) CA1279575C (da)
DE (1) DE3486177T2 (da)
DK (1) DK586784A (da)
FI (1) FI844593L (da)
GR (1) GR81209B (da)
IE (1) IE60713B1 (da)
IL (1) IL73422A0 (da)
IN (1) IN162797B (da)
MX (1) MX156438A (da)
NZ (1) NZ210056A (da)
PT (1) PT79604B (da)
ZA (1) ZA848619B (da)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1987006464A1 (en) * 1986-05-02 1987-11-05 Gaf Corporation Water soluble polyvinyl lactam-drug complexes
US4894239A (en) * 1987-06-02 1990-01-16 Takeda Chemical Industries, Ltd. Sustained-release preparation and production thereof
US5132296A (en) * 1987-08-14 1992-07-21 Cherksey Bruce D Membrane NA+ channel protein and related therapeutic compounds
EP0418597A3 (en) * 1989-09-21 1991-11-27 American Cyanamid Company Controlled release carbonic anhydrase inhibitor containing pharmaceutical compositions from spherical granules in capsule oral dosage unit form
KR100221695B1 (ko) * 1991-08-12 1999-09-15 그린 마틴, 브라이언 쥐 테슬리 약학적 구상 제형
US5721263A (en) * 1993-06-07 1998-02-24 Takeda Chemical Industries, Ltd. Pharmaceutical composition for angiotensin II-mediated diseases
US5994348A (en) * 1995-06-07 1999-11-30 Sanofi Pharmaceutical compositions containing irbesartan
US5980882A (en) * 1997-04-16 1999-11-09 Medeva Pharmaceuticals Manufacturing Drug-resin complexes stabilized by chelating agents
NZ534409A (en) 1999-04-05 2006-03-31 Emisphere Tech Inc Disodium salts, monohydrates, and ethanol solvates for delivering active agents
US8168616B1 (en) 2000-11-17 2012-05-01 Novartis Ag Combination comprising a renin inhibitor and an angiotensin receptor inhibitor for hypertension
DE60232290D1 (de) * 2001-04-09 2009-06-25 Rohm & Haas Kontrollierte Auflösung von Wirkstoffen
US8563592B2 (en) 2001-11-01 2013-10-22 Spectrum Pharmaceuticals, Inc. Bladder cancer treatment and methods
WO2003037314A2 (en) 2001-11-01 2003-05-08 Spectrum Pharmaceuticals, Inc. Medical compositions for intravesical treatment of bladder cancer
GB0325605D0 (en) * 2003-11-03 2003-12-10 Novartis Ag Combination of organic compounds
EP1986640A1 (en) * 2006-02-09 2008-11-05 Spectrum Pharmaceuticals, Inc. Bladder cancer treatment by using e09 and propylene glycol
KR101368997B1 (ko) * 2009-10-20 2014-03-03 재단법인 의약바이오컨버젼스연구단 벤즈티아지드를 유효성분으로 함유하는 항암용 조성물

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL247297A (da) * 1959-01-14
US3781430A (en) * 1962-10-30 1973-12-25 Merck & Co Inc Diuretic formulations
FR3608M (fr) * 1964-02-03 1965-10-11 Merck & Co Inc Compositions diurétiques.
NL7508856A (nl) * 1974-08-16 1976-02-18 Merck & Co Inc Werkwijze voor het bereiden van preparaten tegen hypertensie.
FR2314719A1 (fr) * 1975-04-11 1977-01-14 Roussel Uclaf Nouveau medicament notamment diuretique
GB1525296A (en) * 1975-08-04 1978-09-20 Geistlich Soehne Ag Antibacterial compositions
DE2546577B2 (de) * 1975-10-17 1981-04-02 Sandoz-Patent-GmbH, 7850 Lörrach Feste Stoffe aus Polyvinylpyrrolidon und Ergotalkaloiden
GB1509778A (en) * 1975-10-29 1978-05-04 Leo Pharm Prod Ltd Pharmaceutical composition and dosage units thereof
DE2638716A1 (de) * 1976-08-27 1978-03-02 Ici Gmbh Antihypertensiva
CA1120400A (en) * 1977-12-27 1982-03-23 Zola P. Horovitz Method of treating hypertension and medicaments therefor
CH639273A5 (de) * 1978-09-12 1983-11-15 Hoffmann La Roche Diuretische mittel.
DE3027392A1 (de) * 1980-07-17 1982-02-04 Schering Ag, 1000 Berlin Und 4619 Bergkamen Synergistische kombination eines (beta) -rezeptorenblockers mit einem saluretikum
DE3041812A1 (de) * 1980-11-06 1982-06-16 Hoechst Ag, 6000 Frankfurt Basisch substituierte 5-phenyltetrazole, verfahren zu ihrer herstellung und ihre verwendung als heilmittel
JPS5788117A (en) * 1980-11-21 1982-06-01 Smithkline Corp Gelatin capsule containing triamterene
JPS5933213A (ja) * 1982-07-27 1984-02-23 ミラン・フア−マスウ−テイカルズ・インコ−ポレイテイド 医薬組成物及びその製造方法
JPS5927812A (ja) * 1982-08-05 1984-02-14 Kotobuki Seiyaku Kk ニフエジピン製剤の製造方法
JPS5982314A (ja) * 1982-10-29 1984-05-12 インステイテユト・オルガニチエスコゴ・シンテザ・アカデミイ・ナウク・ラトビイスコイ・エスエスア−ル 抗菌性医薬組成物

Also Published As

Publication number Publication date
JPH10152441A (ja) 1998-06-09
FI844593A7 (fi) 1985-06-10
DK586784A (da) 1985-06-10
JPS60139620A (ja) 1985-07-24
IN162797B (da) 1988-07-09
JPH09278655A (ja) 1997-10-28
AU3641484A (en) 1985-06-13
NZ210056A (en) 1989-01-06
DE3486177D1 (de) 1993-08-19
PT79604A (en) 1985-01-01
FI844593A0 (fi) 1984-11-22
IE843148L (en) 1985-06-09
AU564078B2 (en) 1987-07-30
PT79604B (en) 1986-11-18
IL73422A0 (en) 1985-02-28
US4898729A (en) 1990-02-06
EP0154009A1 (en) 1985-09-11
CA1279575C (en) 1991-01-29
AU602899B2 (en) 1990-11-01
JPH08253418A (ja) 1996-10-01
AU7440287A (en) 1987-10-08
MX156438A (es) 1988-08-22
EP0154009B1 (en) 1993-07-14
IE60713B1 (en) 1994-08-10
GR81209B (en) 1985-04-10
ZA848619B (en) 1985-06-26
FI844593L (fi) 1985-06-10
DE3486177T2 (de) 1994-03-10
ATE91416T1 (de) 1993-07-15

Similar Documents

Publication Publication Date Title
DK586784A (da) Thiazid-blandet anion/kationkompleks
IE890868L (en) Anticalculus oral composition
DK0751769T3 (da) Medicinsk behandling under anvendelse af skjoldbruskhormoner
GEP19970823B (en) Composition for coating of tooth solid tissues
NZ334537A (en) Two phase remineralising composition comprising a source of calcium ions and a source of phosphate ions with a water soluble polyphosphate salt
FI831314L (fi) Kompositioner som befraemjar munhygien
EP0210590A3 (en) Polymeric additives for water
ES422997A1 (es) Procedimiento para preparar agentes ligadores de fosfatos.
CA2101554A1 (en) Solubility compound fertilizer compositions
AU3081389A (en) Anticalculus oral compositions
GB1511196A (en) Creatinine pyrolidonecarboxylate
IE44461L (en) Piperazinyluracil salts
GB1450524A (en) 2,4,6-triiodo-5-methoxyacetamido-n-methylisophthalamic acid and salts acyl halides and esters thereof
AU551108B2 (en) Analgesic potentiation of zomepirac with butorphanol
IE42754L (en) N,n'-substituted naphthalenacetamidines
DE3564423D1 (en) Purification of 4-fluoro-4'-hydroxy-benzophenone
GB1234685A (en) Preparation of pyruvaldehyde
IT1224250B (it) Associzione del depiprazolo con la morfina
FR2160293A1 (en) Aqueous poly(1,1'-dimethyl-1-sila-2,6-dioxa-4-hexanol) compsn - with antiinflammatory and reticuloendothelial activity
IT1275515B (it) Composizione di tipo idrossido misto di alluminio e di alcalinoterrosicome agenti anti-cloro e anti-acidi per la stabilizzazione delle resine termoplastiche
FR2414048A1 (fr) Benzofuro (2,3-c) pyridines, leur procede de preparation et leur application en therapeutique
JPS52119657A (en) Method for preventing degrading of cationic high polymers of mannich type
GB1217415A (en) Triazine derivatives and pharmaceutical formulation and processes for making same
FR2269932A1 (en) Synergistic hypotensive compsns for oral admin - contg reserpine and guancydine
JPS56144745A (en) Water absorbing agent

Legal Events

Date Code Title Description
AHB Application shelved due to non-payment